Skip to main content

Table 6 Indoor resting density and blood feeding rates of An. gambiae s.l. collected by PSCs method after 2019, 2020 and 2021 IRS intervention in communes under IRS

From: Did the prolonged residual efficacy of clothianidin products lead to a greater reduction in vector populations and subsequent malaria transmission compared to the shorter residual efficacy of pirimiphos-methyl?

Communes

Period

Nb of room

Nb of An. gambiae s.l. collected

Nb of blood feed

Rest density per room

Blood feeding rate

Value

RR [95% CI]

P-value

Proportion (%)

P-value

(Wald)

Kandi + Gogounou (under IRS in Alibori)

2019 (PM 300CS)

120

25

20

0.2

1

80.0

2020 (Clo + Del)

120

102

75

0.9

4.08 [2.61–6.60]

 < 0.0001

73.5

0.68

2021 (Clo 50WG)

160

171

125

1.1

5.13 [3.36–8.15]

 < 0.0001

73.1

0.62

Djougou + Copargo (under IRS in Donga)

2019 (PM 300CS)

120

48

34

0.4

1

70.8

2020 (Clo + Del)

120

118

77

1.0

2.46 [1.74–3.51]

 < 0.0001

65.3

0.61

2021 (Clo 50WG)

160

234

214

1.5

3.66 [2.67–5.10]

 < 0.0001

91.5

0.0002

  1. RR: rate ratio; p (wald): p-value of the Wald test; [95% CI]: 95% confidence interval; %: percentage; PM: pirimiphos-methyl; CS: capsule suspensions; WG: Water dispersible granules; Clot + Del: mixture clothianidin 500 g/kg + deltamethrin 62.5 g/kg; Clo 50WG: clothianidin 50 WG